Biotechnology in India: Applications, Regulation and Ethical Issues
18 Nov 2026
Biotechnology in India: Applications, Regulation and Ethical Issues
Biotechnology is one of the most transformative fields of modern science. It combines biology with engineering, genetics, molecular biology, chemistry and information technology to develop products and processes that address challenges in healthcare, agriculture, industry and environmental protection.
From the development of vaccines and life-saving medicines to genetically improved crops, biofuels and pollution management, biotechnology has become an important driver of scientific innovation and economic development. For India, biotechnology has strategic importance because of its potential to strengthen public health, food security, agricultural productivity, industrial manufacturing, environmental sustainability and technological self-reliance.
India's biotechnology sector is also contributing to the expansion of the country's bioeconomy. According to the India Bioeconomy Report 2026, India's bioeconomy was valued at approximately US$195.3 billion in 2025, with the government aiming to expand it to US$300 billion by 2030. This growth reflects the increasing contribution of biopharmaceuticals, agricultural biotechnology, industrial biotechnology and other bio-based activities. However, technological progress also raises concerns regarding biosafety, genetic privacy, human genome editing, biodiversity, intellectual property rights and unequal access to advanced treatments.
UPSC relevance: The topic is directly linked to GS Paper III - Science and Technology: developments and their applications and effects in everyday life; achievements of Indians in science and technology; indigenisation of technology and developing new technology. It also connects with GS Paper II through government policies, regulatory institutions and public health governance.
What is Biotechnology?
Biotechnology refers to the use of living organisms, biological systems, cells or biological processes to develop useful products and technologies.
It involves the application of scientific knowledge to understand, modify or utilise biological processes for human welfare. For example, microorganisms are used to manufacture antibiotics, genetic engineering is used to develop certain medicines, and tissue culture helps produce disease-free planting material.
Types of Biotechnology
Traditional Biotechnology
Traditional biotechnology uses naturally occurring biological processes to manufacture useful products. It has been practised for centuries, even before the development of modern genetic science.
Examples include:
Fermentation in the production of curd, bread and cheese.
Use of yeast in food processing.
Traditional microbial processes used in food preservation.
Modern Biotechnology
Modern biotechnology uses advanced techniques to study, modify and utilise biological material at the cellular and molecular levels. Examples include genetic engineering, recombinant DNA technology, genome sequencing, tissue culture, gene therapy and synthetic biology.
Important Techniques Used in Biotechnology
Difference Between Genetic Engineering and Genome Editing
Genetic engineering and genome editing are related but not identical concepts.
Genetic engineering broadly involves modifying an organism's genetic material, which may include introducing genetic material from another organism.
Genome editing involves making targeted changes at specific locations in the genome using tools such as CRISPR-Cas systems.
Importantly, some genome-editing techniques can modify DNA without introducing foreign DNA. Therefore, not every genome-edited organism is necessarily a genetically modified organism in the same regulatory sense. Its regulatory treatment depends on the technique, organism, intended use and applicable Indian rules.
Applications of Biotechnology in India
Biotechnology has applications across several sectors of the Indian economy. Its significance lies not only in developing new products but also in improving existing production systems and addressing public welfare challenges.
Biotechnology in Healthcare and Medicine
Healthcare is one of the most important applications of biotechnology. It has transformed vaccine development, disease diagnosis, pharmaceutical manufacturing and the treatment of several complex diseases.
Vaccine Development
Biotechnology enables the development of different types of vaccines, including recombinant protein, viral-vector, DNA and mRNA-based vaccines. India has established a strong vaccine manufacturing ecosystem and supplies vaccines for domestic immunisation programmes as well as international markets. The COVID-19 pandemic demonstrated the importance of domestic vaccine research, manufacturing capacity and international scientific collaboration.
Biopharmaceuticals
Biopharmaceuticals are medicines produced using biological systems or living cells. They include recombinant proteins, insulin, monoclonal antibodies and certain vaccines. These products are used in the treatment of diabetes, cancers, autoimmune disorders and several other diseases.
Gene Therapy
Gene therapy aims to treat or prevent disease by introducing, modifying or regulating genetic material in a patient's cells. It has potential applications in inherited disorders, certain cancers and other serious conditions. However, gene therapy products require rigorous evaluation of quality, safety and efficacy before regulatory approval.
Molecular Diagnostics
Techniques such as polymerase chain reaction (PCR), genome sequencing and molecular assays help identify infectious diseases and genetic conditions. These technologies can improve disease detection, surveillance and treatment decisions.
Personalised Medicine
Personalised medicine uses information about an individual's genes, proteins and other biological characteristics to guide treatment. For example, genetic information can help identify patients who may respond better to particular medicines. Its wider adoption in India will require affordable testing, skilled professionals, reliable genomic databases and strong privacy protections.
Biotechnology in Agriculture
Agricultural biotechnology can contribute to food security, crop improvement and sustainable farming.
Genetically Modified Crops
Genetically modified crops are developed by modifying genetic material to introduce selected traits. Bt cotton is India's prominent example of a genetically modified crop approved for commercial cultivation. It contains genetic material derived from Bacillus thuringiensis, which helps protect cotton plants against certain insect pests.
The use of GM crops also raises questions concerning environmental risks, pest resistance, seed access and farmers' economic interests. These issues require scientific assessment and effective regulation.
Genome-Edited Crops
Genome editing can help develop crop varieties with improved disease resistance, nutritional characteristics and tolerance to environmental stress. India has introduced a regulatory pathway for certain categories of genome-edited plants. The treatment of SDN-1 and SDN-2 plants is guided by specific government procedures and safety requirements; it should not be assumed that every genome-edited crop is automatically exempt from regulation.
Tissue Culture
Plant tissue culture allows rapid multiplication of disease-free and genetically uniform planting material under controlled conditions. It is used in crops such as banana, sugarcane, potato and several horticultural plants.
Biofertilisers
Biofertilisers contain beneficial microorganisms that improve nutrient availability and support plant growth. For example, Rhizobium bacteria help leguminous plants fix atmospheric nitrogen, reducing dependence on certain chemical fertilisers.
Biopesticides
Biopesticides use biological organisms or naturally derived substances to manage agricultural pests. Examples include Bacillus thuringiensis, Trichoderma and neem-based formulations. They can support integrated pest management when used appropriately.
Climate-Resilient Agriculture
Biotechnology can support the development of crops that tolerate drought, heat, salinity and certain plant diseases. Such developments are important for India because climate variability poses increasing risks to agricultural productivity and farmers' incomes.
Biotechnology in Industrial Manufacturing
Industrial biotechnology uses microorganisms, enzymes and biological processes to manufacture products. It can support the transition from conventional resource-intensive manufacturing towards more sustainable production systems.
Important applications include:
Bio-based Chemicals: Production of chemicals using biological feedstocks instead of relying entirely on petroleum-based raw materials.
Industrial Enzymes: Enzymes are used in food processing, detergents, textiles, paper and pharmaceutical manufacturing.
Bioplastics: Certain biological processes can produce bio-based or biodegradable plastics. Their environmental benefits depend on the feedstock, manufacturing process and disposal conditions.
Biopharmaceutical Manufacturing: Biological systems are used to manufacture vaccines, therapeutic proteins and other medicines.
Biomanufacturing: Living cells, microorganisms and biological processes are combined with engineering to produce medicines, chemicals, materials and other high-value products at scale.
Biotechnology and Environmental Protection
Biotechnology can contribute to environmental management by using biological processes to reduce pollution and convert waste into useful products.
Bioremediation
Bioremediation uses microorganisms or plants to remove, degrade or immobilise pollutants in contaminated soil and water. For example, certain microorganisms can break down petroleum hydrocarbons in contaminated environments.
Wastewater Treatment
Microorganisms help decompose organic pollutants in sewage and industrial wastewater. Biological treatment processes are widely used in wastewater management.
Biogas Production
Anaerobic digestion converts biodegradable organic matter, including animal dung and certain agricultural wastes, into biogas and nutrient-rich digestate.
Bio-based Alternatives
Biotechnology can help develop alternatives to certain fossil-based chemicals and materials, contributing to a circular bioeconomy. However, the environmental benefits of these alternatives must be evaluated through life-cycle assessment rather than assumed automatically.
Biotechnology in Food and Nutrition
Biotechnology is used in food processing, food safety, nutrition and the development of alternative food products. Important applications include fermentation, enzyme-assisted food processing, microbial food testing and biofortification.
Biofortification refers to increasing the nutritional content of crops through conventional breeding or modern biotechnology.
For example, biofortification may improve the availability of iron, zinc or vitamin A in food crops. The development of smart proteins and fermentation-derived food ingredients is also receiving attention under India's emerging biomanufacturing policy.
Biotechnology in Forensics and National Security
Biotechnology has applications in forensic science, disease surveillance and biological security.
DNA Profiling can assist in criminal investigations and the identification of missing persons and disaster victims, subject to appropriate legal safeguards.
Genomic Surveillance helps monitor the spread and evolution of infectious diseases.
Biosecurity involves preventing the accidental or deliberate misuse of biological agents, research and technologies.
The development of advanced biological tools also raises concerns about dual-use research, where scientific knowledge intended for beneficial purposes could potentially be misused.
India's Biotechnology Ecosystem
India's biotechnology ecosystem includes government departments, research institutions, universities, hospitals, private companies and start-ups. Several initiatives have been introduced to strengthen research, innovation, manufacturing and entrepreneurship.
Department of Biotechnology (DBT)
The Department of Biotechnology, established in 1986 under the Ministry of Science and Technology, is responsible for promoting biotechnology research and development in India.
Its major areas of work include:
Supporting basic and applied biotechnology research.
Developing research infrastructure.
Promoting biotechnology education and skilled human resources.
Encouraging industry-academia collaboration.
Supporting innovation and technology development.
Biotechnology Industry Research Assistance Council (BIRAC)
BIRAC is a not-for-profit public sector enterprise established in 2012 under the Department of Biotechnology. It supports biotechnology innovation and entrepreneurship, particularly among start-ups, small and medium enterprises and research institutions. Its activities include funding assistance, incubation support, mentoring and facilitating the commercialisation of biotechnology products.
Bio-RIDE Scheme
The Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is an initiative aimed at strengthening biotechnology research, innovation and entrepreneurship. It brings together support for biotechnology research and development, industrial and entrepreneurship development, and biomanufacturing-related activities. Its broader objective is to strengthen the link between scientific discoveries and their practical applications.
BioE3 Policy
The BioE3 Policy, which stands for Biotechnology for Economy, Environment and Employment, was approved by the Union Cabinet on 24 August 2024. It aims to promote high-performance biomanufacturing and establish a resilient biotechnology manufacturing ecosystem in India.
The policy focuses on six thematic areas:
The policy envisages the development of Biofoundries, Biomanufacturing Hubs and Bio-AI Hubs. These facilities are intended to provide shared infrastructure for research institutions, start-ups, small businesses and industries, particularly for pilot-scale and pre-commercial manufacturing.
According to a government update dated 23 July 2026, more than 2,000 proposals had been received under BioE3 calls, and over 270 projects had been recommended for funding. These are project-selection figures, not evidence that every recommended project has become operational. The policy also aims to strengthen public-private partnerships, indigenous manufacturing, skilled employment and sustainable industrial growth.
Genome India Project
The Genome India Project aims to develop a representative genomic resource reflecting the genetic diversity of India's population. India has substantial genetic diversity across geographical regions and population groups. Studying this diversity can improve research into inherited diseases, population genetics and precision medicine.
The project can support the development of better diagnostic tools and more representative genetic research. However, genomic information is highly sensitive. Its collection and use require informed consent, privacy safeguards, secure storage and responsible access.
National Biopharma Mission
The National Biopharma Mission, also known as Innovate in India, aims to accelerate the development of biopharmaceutical products and strengthen India's innovation ecosystem. It supports research and development in areas such as vaccines, biosimilars, medical devices and other biological products. The mission promotes collaboration between research institutions, industry and academia to bridge the gap between scientific discoveries and commercial applications.
National Biotechnology Development Strategy
India's biotechnology development strategies have focused on strengthening scientific research, innovation, manufacturing capacity and entrepreneurship. The broader policy objective is to make biotechnology an important contributor to healthcare, agriculture, industrial development and environmental sustainability.
Regulation of Biotechnology in India
Biotechnology regulation is necessary because biological products and processes may affect human health, animals, agriculture, biodiversity and the environment. India does not have a single regulator for every biotechnology application. Different laws and authorities govern genetically engineered organisms, medicines, clinical trials, food products and biomedical research.
Environment (Protection) Act, 1986
The Environment (Protection) Act, 1986 provides the legal foundation for environmental protection in India. Under this Act, the government notified the Rules for the Manufacture, Use, Import, Export and Storage of Hazardous Microorganisms, Genetically Engineered Organisms or Cells, 1989.
These are commonly known as the Rules, 1989.
They regulate specified activities involving hazardous microorganisms and genetically engineered organisms, including research, manufacture, use, import, export, storage and environmental release.
The Rules, 1989 form the foundation of India's biosafety regulatory framework.
Six Competent Authorities under the Rules, 1989
The Rules, 1989 provide for six competent authorities. Their functions are important for UPSC Prelims.
Important UPSC point: GEAC is not the regulator for every biotechnology product. Its role is linked to activities governed by the Rules, 1989.
Genetic Engineering Appraisal Committee (GEAC)
The GEAC functions under the Ministry of Environment, Forest and Climate Change. It appraises and approves specified activities involving genetically engineered organisms under the Rules, 1989, particularly those involving environmental release and certain large-scale uses. For example, proposals involving the environmental release of genetically modified crops fall within the relevant biosafety regulatory framework.
Review Committee on Genetic Manipulation (RCGM)
The RCGM functions under the Department of Biotechnology. It reviews ongoing research involving genetically engineered organisms and hazardous microorganisms and oversees specified research-related biosafety matters. It plays an important role in monitoring biotechnology research and ensuring compliance with applicable guidelines.
Institutional Biosafety Committee (IBSC)
The IBSC is constituted at institutions undertaking research involving hazardous microorganisms or genetically engineered organisms. It monitors biosafety at the institutional level and ensures that research activities follow relevant safety guidelines.
It acts as an important first level of biosafety oversight.
Central Drugs Standard Control Organisation (CDSCO)
The CDSCO, under the Ministry of Health and Family Welfare, regulates drugs, vaccines, biological products and clinical trials under applicable drug laws and rules. Biotechnology-derived medicines and gene therapy products require regulatory scrutiny through the relevant drug approval pathway. The New Drugs and Clinical Trials Rules, 2019 are particularly relevant to clinical research and new drug development.
Food Safety and Standards Authority of India (FSSAI)
The FSSAI regulates food safety and standards under the Food Safety and Standards Act, 2006. Food products derived from biotechnology may require compliance with applicable food safety requirements, in addition to any relevant environmental or biosafety approvals.
Indian Council of Medical Research (ICMR)
The ICMR develops ethical guidelines and standards for biomedical and health research involving human participants.
Its guidance is important for clinical research, informed consent, human genetic research and emerging areas such as gene therapy and stem-cell research.
The National Guidelines for Gene Therapy Product Development and Clinical Trials, 2019, were developed through collaboration involving ICMR, CDSCO and DBT.
Regulatory Framework for Genome Editing
Genome editing has created new regulatory questions because some techniques can modify an organism's DNA without introducing foreign genetic material. India has issued specific guidelines and standard operating procedures for certain categories of genome-edited plants.
The DBT regulatory portal lists the Revised SOPs defining the Regulatory Pathway for Import of SDN-1/SDN-2 Genome-Edited Planting Materials, 2026, along with earlier safety assessment guidelines. This reflects the need for a risk-based regulatory approach that distinguishes between different genome-editing techniques and their potential impacts.
Ethical Issues in Biotechnology
Biotechnology creates opportunities for scientific progress, but it also raises complex ethical questions concerning human dignity, privacy, equality, biodiversity and intergenerational responsibility.
Human Genome Editing
Genome editing may help treat genetic diseases, but editing the human germline raises serious ethical concerns.
There are two important categories:
Somatic Gene Editing: Changes are made in the body cells of an individual. These changes are generally not inherited by future generations.
Germline Editing: Changes are made in reproductive cells or embryos and may be passed on to future generations.
Germline editing raises concerns because future generations cannot consent to genetic changes made before their birth. Unintended mutations, unknown long-term effects and the possibility of genetic enhancement also create ethical challenges. The distinction between treating a serious disease and modifying human traits for non-medical purposes is therefore important.
Genetic Privacy and Data Protection
Genomic information can reveal sensitive details about an individual's health, inherited conditions and biological relationships. Misuse of such information may result in discrimination, unauthorised disclosure or commercial exploitation. India needs strong safeguards for informed consent, secure storage, controlled access and responsible sharing of genetic data.
The Digital Personal Data Protection Act, 2023, together with applicable rules and other legal safeguards, forms part of India's broader data-protection framework. However, genomic information also requires specialised safeguards because its implications may extend to biological relatives and future generations.
Safety of Genetically Modified Organisms
Genetically modified crops may provide benefits such as insect resistance and improved productivity. However, their deployment can raise environmental and agricultural concerns.
These include:
Gene flow from cultivated GM crops to related plants.
Development of resistant pests or weeds.
Possible effects on non-target organisms.
Changes in agricultural practices and seed dependence.
Potential impacts on biodiversity and ecological balance.
These risks should be assessed scientifically on a case-by-case basis. It is not scientifically justified to assume that every GM crop is inherently dangerous or that every GM crop is automatically safe.
Animal Welfare
Biotechnology research may involve laboratory animals, genetic modification and animal testing. Ethical research requires adherence to the 3Rs principle:
Replacement: Use non-animal alternatives wherever scientifically appropriate.
Reduction: Use the minimum number of animals necessary to obtain reliable scientific results.
Refinement: Minimise pain, distress and suffering during research.
India's framework includes the Prevention of Cruelty to Animals Act, 1960, and relevant rules governing animal experimentation, with oversight by the Committee for Control and Supervision of Experiments on Animals.
Unequal Access to Biotechnology
Advanced therapies, genomic testing and personalised medicine may be expensive and concentrated in specialised urban healthcare facilities. If access depends primarily on purchasing power, biotechnology may increase existing inequalities in healthcare. Public investment, affordable pricing, stronger healthcare infrastructure and appropriate regulatory oversight are necessary to ensure equitable access.
Biopiracy and Benefit Sharing
Biopiracy refers to the unauthorised or inequitable use of biological resources and associated traditional knowledge, often without appropriate recognition or benefit sharing. India possesses rich biodiversity and traditional knowledge. Their protection is important for communities that have conserved and developed such resources. The Biological Diversity Act, 2002, as amended in 2023, provides a framework for conservation, sustainable use and fair and equitable sharing of benefits arising from biological resources and associated knowledge.
Dual-Use Research and Biosecurity
Certain biotechnology research can have both beneficial and harmful applications. For example, research involving microorganisms and genetic engineering may support vaccine development and disease prevention, but the same scientific knowledge could potentially be misused.
This creates the challenge of dual-use research. India needs strong biosafety protocols, responsible research practices, laboratory security, institutional oversight and effective monitoring to reduce the risk of biological misuse.
Intellectual Property Rights and Public Interest
Biotechnology innovation often requires substantial investment in research and development. Patent protection can encourage innovation by providing incentives to researchers and companies. However, excessive control over essential technologies may restrict access to medicines, seeds and research tools.
India must balance intellectual property protection with public health, farmers' interests, affordable medicines and scientific research.
Challenges Facing India's Biotechnology Sector
Despite significant progress, India's biotechnology ecosystem faces several structural challenges.
Limited Research-to-Market Translation
India has a strong scientific talent base, but converting laboratory discoveries into commercially successful products remains difficult. Long development cycles, limited risk capital and insufficient pilot-scale infrastructure can delay commercialisation.
Dependence on Imported Inputs
Certain advanced laboratory equipment, reagents, specialised materials and manufacturing technologies continue to depend on international supply chains. This increases costs and creates vulnerabilities during global disruptions.
Weak Industry-Academia Linkages
Research institutions may generate promising discoveries, but collaboration with industries is not always sufficient to translate these discoveries into commercial products. Stronger technology transfer mechanisms and industry partnerships are needed.
Regulatory Complexity
Different biotechnology products may require approvals from multiple authorities. Unclear responsibilities, limited regulatory capacity and lengthy approval processes can affect innovation and public confidence. The solution is not to weaken safety standards but to improve coordination, transparency, scientific expertise and predictable approval procedures.
Shortage of Skilled Professionals
Advanced biotechnology requires specialists in molecular biology, genomics, bioinformatics, bioprocess engineering, clinical research and regulatory science. India needs more interdisciplinary education and specialised training programmes.
Biosafety and Public Trust
Public confidence may be weakened by inadequate communication, limited transparency and exaggerated claims about biotechnology products. Regulatory decisions should be based on scientific evidence and supported by transparent risk assessments.
Way Forward: Building a Safe and Competitive Biotechnology Ecosystem
Strengthen Research and Development: Increase sustained public and private investment in basic research, translational science and high-risk innovation. Research institutions should receive support to move promising discoveries towards practical applications.
Improve Regulatory Coordination: Strengthen coordination among DBT, RCGM, GEAC, CDSCO, FSSAI, ICMR and other relevant institutions. Publish clear regulatory pathways and make scientific risk assessments accessible to the public.
Expand Domestic Biomanufacturing: Implement BioE3 through shared infrastructure, biofoundries, biomanufacturing hubs and industry-academia partnerships. Focus on quality, affordability, scalability and global competitiveness.
Promote Responsible Innovation: Establish strong ethical review mechanisms, informed-consent procedures, genetic privacy safeguards and biosafety protocols for emerging technologies such as genome editing and synthetic biology.
Ensure Affordable Access: Encourage public-sector research, local manufacturing, technology transfer and appropriate pricing mechanisms so that biotechnology benefits reach rural populations and economically weaker sections.
Develop Skilled Human Resources: Expand interdisciplinary education and training in genomics, bioinformatics, bioprocess engineering, clinical research, regulatory affairs and bioethics.
Protect Biodiversity and Traditional Knowledge: Strengthen implementation of benefit-sharing provisions and ensure community participation in decisions involving biological resources.
Build International Partnerships: Collaborate on vaccine research, disease surveillance, biosecurity, scientific standards and responsible technology development while protecting India's strategic interests.
Conclusion
Biotechnology can become a major driver of India's transition towards a knowledge-based, sustainable and innovation-led economy. Its applications in healthcare, agriculture, industrial manufacturing and environmental management offer significant opportunities for inclusive development. However, scientific progress cannot be measured only by the number of patents, start-ups or products developed. It must also be evaluated in terms of safety, affordability, environmental sustainability, ethical accountability and equitable access.
India's objective should be to build a biotechnology ecosystem that is globally competitive, scientifically responsible and socially inclusive. The success of initiatives such as BioE3 will depend on India's ability to connect research, regulation, manufacturing and public welfare.
UPSC Prelims Practice Questions
Q.1With reference to biotechnology, consider the following statements:
Recombinant DNA technology involves combining DNA sequences from different sources.
CRISPR-Cas9 can be used for targeted genome editing.
All genome-editing techniques necessarily introduce foreign DNA into an organism.
Which of the statements given above are correct?
(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3
Answer: (a) 1 and 2 only
Explanation: Recombinant DNA technology combines DNA sequences from different sources. CRISPR-Cas9 is a genome-editing tool that can make targeted changes. Genome editing does not necessarily involve introducing foreign DNA.
Q.2With reference to the Rules, 1989, consider the following statements:
They were notified under the Environment (Protection) Act, 1986.
They regulate specified activities involving genetically engineered organisms and hazardous microorganisms.
They are administered exclusively by the Ministry of Agriculture and Farmers Welfare.
Which of the statements given above are correct?
(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3
Answer: (a) 1 and 2 only
Explanation: The Rules, 1989 were notified under the Environment (Protection) Act, 1986. Their implementation involves multiple authorities, including MoEFCC, DBT and state-level institutions.
Q.3Which of the following best describes the role of the Genetic Engineering Appraisal Committee (GEAC)?
(a) Regulating all clinical trials in India
(b) Appraising specified activities involving genetically engineered organisms, including environmental release
(c) Regulating all pharmaceutical manufacturing
(d) Granting patents for genetically modified organisms
Answer: (b)
Explanation: GEAC functions under MoEFCC and performs appraisal and approval functions under the Rules, 1989. CDSCO has a distinct role in regulating drugs and clinical trials.
Q.4Consider the following pairs:
How many of the pairs given above are correctly matched?
(a) Only one
(b) Only two
(c) All three
(d) None
Answer: (c) All three
Explanation: All three pairs are correctly matched. Bioremediation uses biological systems to manage contamination, tissue culture supports controlled multiplication of plant material, and bioinformatics applies computational methods to biological data.
Q.5The term 'bioeconomy' is best understood as:
(a) An economy based exclusively on agricultural exports
(b) Economic activity based on the use of biological resources, processes and knowledge
(c) An economy that prohibits the use of synthetic materials
(d) An economic system limited to traditional medicines
Answer: (b)
Explanation: Bioeconomy includes economic activities based on biological resources, biotechnology and bio-based processes across healthcare, agriculture, industry, energy and environmental management.
Q.6With reference to the BioE3 Policy, consider the following statements:
It was approved by the Union Cabinet in August 2024.
It aims to promote high-performance biomanufacturing.
It focuses only on vaccine manufacturing.
Which of the statements given above are correct?
(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3
Answer: (a) 1 and 2 only
Explanation: BioE3 was approved in August 2024 and covers six thematic areas, including bio-based chemicals, smart proteins, precision biotherapeutics, climate-resilient agriculture, carbon capture and marine and space research. It is not limited to vaccines.
Q.6Which of the following is associated with the principle of Replacement, Reduction and Refinement?
(a) Genetic patenting
(b) Ethical use of animals in scientific research
(c) Commercial cultivation of GM crops
(d) Clinical approval of vaccines
Answer: (b)
Explanation: The 3Rs are principles for improving animal welfare in scientific research. Replacement promotes alternatives to animal use, Reduction minimises the number of animals used, and Refinement reduces suffering.
Q.7With reference to gene therapy, consider the following statements:
It seeks to treat disease by introducing, modifying or regulating genetic material.
Every gene therapy product is automatically exempt from clinical-trial requirements.
Gene therapy can have applications in inherited disorders.
Which of the statements given above are correct?
(a) 1 and 3 only
(b) 2 and 3 only
(c) 1 and 2 only
(d) 1, 2 and 3
Answer: (a) 1 and 3 only
Explanation: Gene therapy involves genetic material or its regulation to treat disease and may be used for inherited disorders. It is subject to applicable regulatory and clinical requirements; it is not automatically exempt.
Q.8Which of the following best describes biopiracy?
(a) Unauthorised or inequitable use of biological resources and associated traditional knowledge
(b) Use of microorganisms for wastewater treatment
(c) Development of vaccines using recombinant DNA
(d) Conservation of biodiversity through protected areas
Answer: (a)
Explanation: Biopiracy concerns the unauthorised or inequitable appropriation of biological resources and associated traditional knowledge, often without appropriate recognition or benefit sharing.
Q.9With reference to BIRAC, consider the following statements:
It was established in 2012.
It supports biotechnology innovation and entrepreneurship.
It functions as India's statutory authority for environmental release of GM crops.
Which of the statements given above are correct?
(a) 1 and 2 only
(b) 2 and 3 only
(c) 1 and 3 only
(d) 1, 2 and 3
Answer: (a) 1 and 2 only
Explanation: BIRAC was established in 2012 as a public sector enterprise under DBT to support biotechnology innovation and entrepreneurship. GEAC performs the relevant appraisal functions under the Rules, 1989; BIRAC is not the statutory authority for environmental release of GM crops.
UPSC Mains Practice Questions
Discuss the role of biotechnology in improving India's healthcare and agricultural sectors. | 10 Marks | 150 Words
Biotechnology has the potential to transform India's bioeconomy. Examine the opportunities and challenges associated with its development. | 15 Marks | 250 Words
Explain India's biotechnology regulatory framework with special reference to the Environment (Protection) Act, 1986 and Rules, 1989.| 15 Marks | 250 Words
Discuss the role of regulatory institutions in ensuring the safe and ethical development of biotechnology in India.| 10 Marks | 150 Words
Genome editing offers significant opportunities in healthcare and agriculture but raises ethical and biosafety concerns. Analyse.| 15 Marks | 250 Words
Examine the significance of the BioE3 Policy in promoting high-performance biomanufacturing and sustainable economic growth in India.| 15 Marks | 250 Words
Frequently Asked Questions (FAQs)
1. What is biotechnology?
Biotechnology is the application of biological organisms, cells, systems and processes to develop products and technologies for healthcare, agriculture, industry, food production and environmental management.
2. What are the major applications of biotechnology in India?
Major applications include vaccine and medicine development, genetic diagnostics, agricultural biotechnology, tissue culture, biofertilisers, biopesticides, industrial enzymes, biofuels, bioremediation and biomanufacturing.
3. Which ministry is responsible for biotechnology in India?
The Department of Biotechnology (DBT) functions under the Ministry of Science and Technology and supports biotechnology research, innovation, infrastructure and entrepreneurship.
4. What is the BioE3 Policy?
The BioE3 Policy, approved in August 2024, stands for Biotechnology for Economy, Environment and Employment. It aims to promote high-performance biomanufacturing through shared facilities such as biofoundries, biomanufacturing hubs and Bio-AI hubs.
5. What are the Rules, 1989?
The Rules, 1989 are regulations notified under the Environment (Protection) Act, 1986. They govern specified activities involving hazardous microorganisms and genetically engineered organisms, including research, manufacture, use, import, export, storage and environmental release.
6. What is the role of GEAC in India?
The Genetic Engineering Appraisal Committee (GEAC), under the Ministry of Environment, Forest and Climate Change, appraises and approves specified activities involving genetically engineered organisms under the Rules, 1989, particularly those involving environmental release and certain large-scale uses.
7. What is the difference between genetic engineering and genome editing?
Genetic engineering broadly involves modifying genetic material, which may include introducing genes from another organism. Genome editing uses targeted tools such as CRISPR-Cas9 to alter selected DNA sequences. Some genome-editing approaches do not introduce foreign DNA.
8. What are the ethical concerns associated with biotechnology?
Major concerns include human germline editing, genetic privacy, unequal access to advanced therapies, animal welfare, environmental risks of GM organisms, biopiracy and the potential misuse of biological research.
9. What is the Genome India Project?
The Genome India Project is a national initiative to create a representative genomic resource reflecting India's genetic diversity. It can support research in precision medicine, genetic diseases and population genomics, subject to appropriate privacy and consent safeguards.
10. What is the significance of biotechnology for UPSC GS Paper III?
Biotechnology is relevant to GS Paper III because the syllabus covers developments in science and technology, their applications and effects in everyday life, and indigenisation of technology. Its applications in agriculture, healthcare, industrial manufacturing and environmental protection make it an important interdisciplinary topic.
For more UPSC-oriented articles and preparation resources, explore The Study IAS.
Subscribe to our Youtube Channel for more Valuable Content –TheStudyias
Download the App to Subscribe to our Courses –Thestudyias
The Source’s Authority and Ownership of the Article is Claimed ByTHE STUDY IAS BY MANIKANT SINGH
Comments (0)
Leave a Comment